Alnylam Pharmaceuticals, Inc. (ALNY)

391.17 -0.33 (-0.08%) USD  |  NASDAQ  |  Dec 16, 16:00
391.23 +0.06 (+0.02%) Pre-Market: 08:18
More

Alnylam Pharmaceuticals Normalized Basic EPS (Quarterly)

Normalized Basic EPS (Quarterly) Chart

View Normalized Basic EPS (Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Basic EPS (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Basic EPS (Quarterly) Range, Past 5 Years

View Normalized Basic EPS (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Basic EPS (Quarterly) Benchmarks

View Normalized Basic EPS (Quarterly) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade
Amgen, Inc. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade